Abstract
Purpose :
TLR3 activation is considered to play important roles in the pathogenesis of herpes simplex keratitis (HSK). It was found that NGF could effectively treat HSK and prevent the relapse of the disease, whilst the detailed mechanisms remain unclear. The aim of this study is to investigate the effects of NGF on inflammatory responses and oxidative injury triggered by TLR3 activation in human corneal epithelial cells (HCECs) in vitro.
Methods :
HCECs were stimulated with TLR3 ligand, poly(I:C), in the absence or presence of NGF. Levels of proinflammatory were measured by ELISA or RT-PCR. NF-κB activation was examined using Western blotting and immunofluorescence staining. The levels of ROS generation were measured by DCF-DA method, and the expression of oxidative marker, mitochondria DNA 8-OHdG was observed.
Results :
In HCECs, poly(I:C) stimulation increased the secretion of proinflammatory cytokines, while such efforts could be attenuated by NGF treatment, probably through its inhibition on NF-κB activation. In addition, the increased generation of ROS and the elevated oxidative injury caused by TLR3 activation were ameliorated by NGF.
Conclusions :
Nerve growth factor could inhibit inflammation and oxidative injury in HCECs, suggesting that NGF might be a novel therapeutic agent for herpes simplex keratitis.
This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.